Skip to main content
. 2021 Mar 10;11:628706. doi: 10.3389/fonc.2021.628706

Figure 3.

Figure 3

(A) Pooled relative effects of all treatment comparisons in the NMA. Pooled HRs (95% CrIs) for PFS/DFS (upper triangle) and OS (lower triangle). Data in each cell are HRs (95% CrIs) for the comparison of row- versus column-defining treatment for PFS/DFS or the comparison of column- versus row-defining treatment for OS. Statistically confident results are in bold. NCRT-S, neoadjuvant chemoradiotherapy followed by surgery; NCT-S, neoadjuvant CT followed by surgery; NRT-S, neoadjuvant RT followed by surgery; S, surgery; S-ACRT, surgery followed by adjuvant CRT; S-ACT, surgery followed by adjuvant CT; S-ART, surgery followed by adjuvant RT. (B) Pooled relative effects of all treatment comparisons in the NMA. Pooled ORs (95% CrIs) for distant metastasis (upper triangle) and locoregional recurrence (lower triangle). Data in each cell are ORs (95% CrIs) for the comparison of row- versus column-defining treatment for distant metastasis or the comparison of column- versus row-defining treatment for locoregional recurrence. Statistically confident results are in bold. NCRT-S, neoadjuvant CRT followed by surgery; NCT-S, neoadjuvant CT followed by surgery; NRT-S, neoadjuvant RT followed by surgery; S, surgery; S-ACRT, surgery followed by adjuvant CRT; S-ACT, surgery followed by adjuvant CCT; S-ART, surgery followed by adjuvant RT.